Krishna Institute of Medical Sciences Ltd. News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Krishna Institute of Medical Sciences Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Krishna Institute of Medical Sciences Ltd.
Rating: 3
Author: ICICI Securities Limited

Keep track of all breaking news and updates on Krishna Institute of Medical Sciences Ltd. from all sources in a single place.

Load latest

Krishna Institute of Medical Sciences Ltd.

09 Feb 2025

622.50

1.57%

Strong momentum across clusters; seasonality drags margins

Hold: Krishna Institute of Medic...

ICICI Securities Limited

Krishna Institute of Medical Sciences’ (KIMS) Q3FY25 revenue was in-line while EBITDA and PAT were dragged by seasonality and its new Nashik hospitals. KIMS’ hospitals in Telangana/Andhra Pradesh grew a robust 26.1%/27.8% YoY. In Q3FY25, it commenced operations at its 325-bed hospital in Nashik (EBITDA loss of INR 50mn in Q3FY25), which is likely to break even by Q3FY26.

Number of FII/FPI investors increased from 195 to 206 in Dec 2024 qtr.

Krishna Institute of Medical Sciences Ltd.

07 Feb 2025

622.50

1.57%

Earnings Call

Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor …

BSE India

Please note that the audio recording of the Company's Conference Call dated February 7, 2025 with Investors/ Analysts for Q3 FY25 is available on the Company''s website at : https://www.kimshospitals.com/investors.

pdf

Krishna Institute of Medical Sciences Ltd.

07 Feb 2025

622.50

1.57%

Company Update

Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor …

BSE India

Meeting with Axis Capital

pdf

Krishna Institute of Medical Sciences Ltd.

07 Feb 2025

622.50

1.57%

to see Rapid results content

Krishna Institute of Medical Sciences Ltd.

07 Feb 2025

622.50

1.57%

Company Update

Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

A copy of newspaper publication on the unaudited (Standalone & Consolidated) financial results for the 3rd Quarter and nine months ended 31st December 2024 is enclosed.

pdf

Krishna Institute of Medical Sciences Ltd.

07 Feb 2025

622.50

1.57%

All eyes on execution in new clusters

Buy: Krishna Institute of Medic...

Emkay

KIMS’s Q3FY25 revenues were ahead of Street/our estimates, while profitability lagged owing to certain write-offs in Maharashtra and AP clusters, and losses in the Nashik hospital.

Promoters unpledged 3.22% of shares in last quarter. Total pledge stands at 12.13% of promoter holdings

Krishna Institute of Medical Sciences Ltd.

06 Feb 2025

622.50

1.57%

Company Update

Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Press Release / …

BSE India

Press Release on the un-audited (Standalone & Consolidated) financial results for the Q3FY2025.

pdf

Krishna Institute of Medical Sciences Ltd.

06 Feb 2025

622.50

1.57%

Investor Presentation

Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation for Q3FY25

pdf

Krishna Institute of Medical Sciences Ltd.

06 Feb 2025

622.50

1.57%

Corp. Note

Krishna Institute of Medical Sciences Ltd - 543308 - Integrated Filing (Financial)

BSE India

Integrated Filing (Financial) for the 3rd Quarter and Nine months ended 31st December, 2024.

pdf

Krishna Institute of Medical Sciences Ltd.

06 Feb 2025

622.50

1.57%

Result

Krishna Institute of Medical Sciences Ltd - 543308 - Quarterly Result 31St December, 2024

BSE India

Quarterly Results_31st December, 2024

pdf

	Dec 2024	Sep 2024	Dec 2023	Change QoQ%	Change YoY%
Total Revenue Qtr	790.20	782.30	609.09	1.0%	29.7%
Operating Profit Qtr	187.20	218.10	147.12	-14.2%	27.2%
Net Profit Qtr	88.70	107.40	71.84	-17.4%	23.5%
Earning Per Share Adjusted latest Qtr	2.22	2.68	1.80	-17.2%	23.3%